As more people turn to GLP-1 agonists (such as semaglutide) for weight loss, nutrient deficiencies appear to be rising. Although hard data doesn’t yet exist on how many people taking Ozempic ...

The study was retrospective, but it included more than 2500 patients taking a GLP-1 or one of the two comparators, reported Varun Sundaram, MD, PhD, section chief, Advanced Heart Failure ...

Aon researchers found that within two years, improved health outcomes for patients who were taking GLP-1 drugs lowers the growth rate of medical care costs. Aon looked at medical claims data for ...

A new study has found GLP-1s may reduce the risk of developing obesity-related cancers by 41% compared to bariatric surgery — a benefit researchers believe could be tied to the drugs’ ability ...

GLP-1 Weight Loss Drugs Cut Alcohol Cravings By Two-Thirds By Dennis Thompson HealthDay ReporterTUESDAY, May 13, 2025 (HealthDay News) — Cutting-edge weight-loss drugs like Ozempic/Wegovy can ...

GLP-1 weight loss treatment can be pricey. But employers who cover the treatments could end up saving on employee medical expenses overall. The finding is according to a new analysis of health ...

A new study links two widely prescribed diabetes drugs to a 33–43% lower risk of Alzheimer’s and related dementias, offering hope for repurposing existing treatments to tackle one of aging’s ...

For many, the big question is whether the pricey medications known as GLP-1s will pay off by improving worker health and lowering overall health costs over time. Analysts at Aon say it's already ...